Biological Treatment - Antimigraine 2026 Tender - 143095828

Procurement Summary

Country: Czech Republic

Summary: Biological Treatment - Antimigraine 2026

Deadline: 13 Jul 2026

Posting Date: 11 Jun 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 143095828

Document Ref. No.: 401335-2026

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: CZK 1217652.75

CPV Classification

33660000 - Medicinal products for the nervous system and sensory organs

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

5. Eptinezumab (N02CD05) 3. Atogepant (N02CD07) 2. Erenumab (N02CD01) 1. Fremanezumab (N02CD03) 4. Galcanezumab (N02CD02) The subject of the public contract is the continuous supply of medicinal products - antimigraine, to the extent according to the needs of the contracting authority. More detailed specifications are listed in Annex No. 3 of this procurement documentation (Price offer (Annex No. 3.1 - No. 3.5)). Doc Title: Biological treatment - Antimigraine 2026 Contract Type: supplies
Document Type: Contract Notice Reference Number: 26039 Contract Type: supplies Estimated Value: 1217652.75 - CZK Authority Type: body-pl-cga Doc Title: Biologická léčba – Antimigrenika 2026 Dispatch Date: 2026-06-10 Publish Date: 2026-06-11 Submission Date: 2026-07-13

Documents

 Tender Notice